Is the Oncotype DX Colon Cancer Assay covered by health insurance?
It is unknown at this time whether carriers will initiate coverage of the Oncotype DX Colon Cancer Assay for patients with stage II colon cancer following surgery. Genomic Health has a program called the Genomic Access Program (GAP) that can help you verify whether or not your insurance covers the test and, if so, can help you obtain reimbursement. Genomic Health also has a patient assistance program. For more information, visit our Insurance Information section. Click here for more information about insurance coverage and reimbursement.